17-CD33CART: Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia (clinicaltrials.gov) - Jun 18, 2025 - P1/2 | N=52 | Recruiting | Sponsor: Center for International Blood and Marrow Transplant Research | Active, not recruiting ➔ Recruiting
Enrollment open • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
|